These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 16001632

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G, Scarpa A, Puppa G, Veronesi G, Spaggiari L, Pasini F, Maisonneuve P, Iannucci A, Arrigoni G, Viale G.
    Cancer; 2005 Mar 15; 103(6):1154-64. PubMed ID: 15712207
    [Abstract] [Full Text] [Related]

  • 3. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.
    Strosberg J, Nasir A, Coppola D, Wick M, Kvols L.
    Hum Pathol; 2009 Sep 15; 40(9):1262-8. PubMed ID: 19368957
    [Abstract] [Full Text] [Related]

  • 4. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
    Coppola D, Clarke M, Landreneau R, Weyant RJ, Cooper D, Yousem SA.
    Mod Pathol; 1996 May 15; 9(5):484-90. PubMed ID: 8733762
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.
    Panzuto F, Nasoni S, Falconi M, Corleto VD, Capurso G, Cassetta S, Di Fonzo M, Tornatore V, Milione M, Angeletti S, Cattaruzza MS, Ziparo V, Bordi C, Pederzoli P, Delle Fave G.
    Endocr Relat Cancer; 2005 Dec 15; 12(4):1083-92. PubMed ID: 16322345
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H, Zizi-Sermpetzoglou A, Elemenoglou I, Papatheofanis I, Peros G, Athanasas G, Panousopoulos D.
    Pol J Pathol; 2006 Dec 15; 57(3):149-59. PubMed ID: 17219742
    [Abstract] [Full Text] [Related]

  • 8. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
    Grabowski P, Griss S, Arnold CN, Hörsch D, Göke R, Arnold R, Heine B, Stein H, Zeitz M, Scherübl H.
    Neuroendocrinology; 2005 Dec 15; 81(1):1-9. PubMed ID: 15809513
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
    Rorstad O.
    J Surg Oncol; 2005 Mar 01; 89(3):151-60. PubMed ID: 15719376
    [Abstract] [Full Text] [Related]

  • 11. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
    Boo YJ, Park SS, Kim JH, Mok YJ, Kim SJ, Kim CS.
    J Surg Oncol; 2007 Feb 01; 95(2):110-7. PubMed ID: 17066436
    [Abstract] [Full Text] [Related]

  • 12. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
    Al-Moundhri MS, Nirmala V, Al-Hadabi I, Al-Mawaly K, Burney I, Al-Nabhani M, Thomas V, Ganguly SS, Grant C.
    J Surg Oncol; 2005 Sep 15; 91(4):243-52. PubMed ID: 16121348
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic value of CD44 isoform expression in thymic epithelial neoplasms.
    Sonobe S, Miyamoto H, Nobukawa B, Izumi H, Futagawa T, Ishikawa N, Yamazaki A, Uekusa T, Abe H, Suda K.
    Cancer; 2005 May 15; 103(10):2015-22. PubMed ID: 15830350
    [Abstract] [Full Text] [Related]

  • 17. Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer.
    Sakai K, Kaku T, Kamura T, Kinukawa N, Amada S, Shigematsu T, Hirakawa T, Kobayashi H, Ariyoshi K, Nakano H.
    Gynecol Oncol; 1999 Mar 15; 72(3):360-6. PubMed ID: 10053108
    [Abstract] [Full Text] [Related]

  • 18. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.
    Wang X, Jones TD, Maclennan GT, Yang XJ, Lopez-Beltran A, Eble JN, Koch MO, Lin H, Baldridge LA, Tretiakova M, Cheng L.
    Anticancer Res; 2005 Mar 15; 25(3B):2001-4. PubMed ID: 16158936
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec 15; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.